Strain Information | |
---|---|
Image | |
BRC No. | RBRC04396 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6.129-Crym<tm1Sasu> |
Former Common name | CRYM -/- mice |
H-2 Haplotype | |
ES Cell line | |
Background strain | |
Appearance | |
Strain development | Developed by Satoru Suzuki, Institute on Aging and Adaptation, Shinshu University in 2004. The mutant mice were backcrossed to C57BL/6J over 6 times. |
Strain description | |
Colony maintenance | |
References | {mu}-Crystallin, new candidate protein in endotoxin-induced uveitis. Imai H, Ohta K, Yoshida A, Suzuki S, Hashizume K, Usami S, Kikuchi T Invest. Ophthalmol. Vis. Sci., 51, 3554-3559 (2010). 20570996 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Crym MGI:102675 | crystallin, mu | 7 | Crym<tm1Sasu> MGI:3703787 | targeted mutation 1, Satoru Suzuki |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | more 5 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | E.coli Neomycin resistance gene, mouse phosphoglycerate kinase promoter (PGK promoter), mouse Crym genomic DNA |
Research application | |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Invest Ophth Vis Sci 51(7):3554-9 (2010). |
Depositor | Satoru Suzuki (Shinshu University) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
Seko D, Ogawa S, Li TS, Taimura A, Ono Y. μ-Crystallin controls muscle function through thyroid hormone action. FASEB J 30(5) 1733-40(2016) 26718889 |